Drug Profile
Pitavastatin - Lupin Pharmaceuticals
Alternative Names: Nikita; Pitavastatin sodiumLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Lupin Pharmaceuticals
- Class Antihyperlipidaemics; Carboxylic acids; Cyclopropanes; Fluorobenzenes; Quinolines; Small molecules
- Mechanism of Action HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Hyperlipidaemia
Most Recent Events
- 15 Jan 2018 Pitavastatin is not yet launched for Hyperlipidaemia in USA (PO) (Literature review)
- 17 Aug 2017 Chemical structure information added
- 09 Aug 2017 Lupin Pharmaceuticals has patent protection for pitavastatin sodium, worldwide